|
Q2 2022
Filed on Jul 15, 2022
|
8,099
|
$18.91 - $26.22
$153K - $212K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
30,470
|
$57.28 - $81.19
$1.75M - $2.47M
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
15,690
|
$13.45 - $15.18
$211K - $238K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
11,004
|
$11.79 - $14.27
$130K - $157K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
5,198
|
$42.63 - $52.77
$222K - $274K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
17,664
|
$8.15 - $10.19
$144K - $180K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
3,622
|
$59.16 - $66.36
$214K - $240K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
1,386
|
$184.24 - $201.29
$255K - $279K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
11,138
|
$7.04 - $9.61
$78.4K - $107K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
16,402
|
$14.42 - $22.55
$237K - $370K
|
|
|
Q2 2021
Filed on Jul 15, 2021
|
29,694
|
$68.32 - $82.2
$2.03M - $2.44M
|
|
|
Q2 2021
Filed on Jul 15, 2021
|
1,210
|
$244.58 - $272.16
$296K - $329K
|
|
Alexion Pharmaceuticals, I
|
Q1 2021
Filed on Apr 16, 2021
|
13,550
|
N/A
|
|
|
Q1 2021
Filed on Apr 16, 2021
|
37,447
|
$43.94 - $62.1
$1.65M - $2.33M
|
|
|
Q4 2020
Filed on Jan 19, 2021
|
1,606
|
$236.26 - $355.63
$379K - $571K
|
|
|
Q3 2020
Filed on Oct 19, 2020
|
34,059
|
$49.27 - $56.87
$1.68M - $1.94M
|
|
|
Q3 2020
Filed on Oct 19, 2020
|
25,032
|
$34.67 - $43.16
$868K - $1.08M
|
|
|
Q3 2020
Filed on Oct 19, 2020
|
24,380
|
$47.12 - $71.95
$1.15M - $1.75M
|
|
|
Q3 2020
Filed on Oct 19, 2020
|
7,780
|
$24.94 - $34.57
$194K - $269K
|
|
|
Q3 2020
Filed on Oct 19, 2020
|
5,989
|
$56.68 - $64.29
$339K - $385K
|
|
|
Q3 2020
Filed on Oct 19, 2020
|
6,376
|
$46.45 - $59.54
$296K - $380K
|
|
|
Q2 2020
Filed on Jul 23, 2020
|
1,586
|
N/A
|
|
|
Q2 2020
Filed on Jul 23, 2020
|
1,561
|
$151.85 - $200.48
$237K - $313K
|
|
|
Q2 2020
Filed on Jul 23, 2020
|
2,303
|
N/A
|
|
|
Q2 2020
Filed on Jul 23, 2020
|
17,484
|
N/A
|
|
|
Q1 2020
Filed on May 07, 2020
|
10,156
|
$13.71 - $26.71
$139K - $271K
|
|
|
Q1 2020
Filed on May 07, 2020
|
2,955
|
$94.39 - $123.48
$279K - $365K
|
|
|
Q1 2020
Filed on May 07, 2020
|
6,657
|
$20.22 - $29.74
$135K - $198K
|
|
|
Q1 2020
Filed on May 07, 2020
|
15,107
|
$8.12 - $25.93
$123K - $392K
|
|
|
Q1 2020
Filed on May 07, 2020
|
7,955
|
$9.3 - $51.9
$74K - $413K
|
|
|
Q1 2020
Filed on May 07, 2020
|
52,373
|
$60.3 - $76.61
$3.16M - $4.01M
|
|
|
Q1 2020
Filed on May 07, 2020
|
2,934
|
$37.68 - $74.06
$111K - $217K
|
|
|
Q4 2019
Filed on Jan 31, 2020
|
22,177
|
$74.19 - $92.86
$1.65M - $2.06M
|
|
|
Q4 2019
Filed on Jan 31, 2020
|
16,830
|
$94.31 - $138.48
$1.59M - $2.33M
|
|
Vaneck Vectors Amt Free Short
|
Q4 2019
Filed on Jan 31, 2020
|
10,870
|
N/A
|
|
Preferred Apt Communities Cl A
|
Q4 2019
Filed on Jan 31, 2020
|
11,931
|
N/A
|
|
|
Q3 2019
Filed on Oct 21, 2019
|
41,140
|
N/A
|
|
|
Q3 2019
Filed on Oct 21, 2019
|
6,085
|
$29.5 - $56.97
$180K - $347K
|
|
Fidelity Inv Money Market
|
Q2 2019
Filed on Jul 15, 2019
|
116,289
|
N/A
|
|
|
Q1 2019
Filed on Apr 29, 2019
|
2,474
|
$157.19 - $185.62
$389K - $459K
|
|
|
Q1 2019
Filed on Apr 29, 2019
|
2,454
|
$116.9 - $143.14
$287K - $351K
|
|
|
Q1 2019
Filed on Apr 29, 2019
|
5,174
|
$44.69 - $49.79
$231K - $258K
|
|
|
Q1 2019
Filed on Apr 29, 2019
|
17,218
|
$108.6 - $161.18
$1.87M - $2.78M
|
|
|
Q3 2018
Filed on Oct 31, 2018
|
5,459
|
N/A
|
|
|
Q3 2018
Filed on Oct 31, 2018
|
6,205
|
$41.91 - $45.31
$260K - $281K
|
|
|
Q3 2018
Filed on Oct 31, 2018
|
6,962
|
$43.35 - $48.49
$302K - $338K
|
|
|
Q3 2018
Filed on Oct 31, 2018
|
26,694
|
$200.49 - $221.81
$5.35M - $5.92M
|
|
|
Q3 2018
Filed on Oct 31, 2018
|
100
|
N/A
|
|
|
Q2 2018
Filed on Aug 13, 2018
|
26,386
|
N/A
|
|
|
Q2 2018
Filed on Aug 13, 2018
|
45,738
|
$64.88 - $75.68
$2.97M - $3.46M
|
|